Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Pappas Capital is a venture capital and commercial development firm based in Durham, North Carolina, founded 31 years ago. The firm manages over 100 portfolio companies and focuses on life sciences, agriculture, and technology sectors. Pappas Capital operates three lines of business: Pappas Ventures, Specialized Fund Management, and Translational Medicine.
Pappas Capital invests in innovative life science, agriculture, and technology companies, with check sizes varying based on the specific investment vehicle. Their approach includes funding early-stage life science companies through Pappas Ventures and creating customized investment vehicles via Specialized Fund Management. Collaborations with academic institutions are central to their strategy, aiming to accelerate scientific discoveries and improve patient outcomes.
Notable companies in Pappas Capital's portfolio include Aktis Oncology, which develops targeted alpha radiopharmaceuticals; Achillion, focused on hepatitis C treatments; Aer Therapeutics, dedicated to muco-obstructive lung diseases; Athersys, known for its MultiStem® stem cell platform; and Istari Oncology, innovating in immuno-oncology.
Submit your pitch through their website's contact form at [URL] or email your deck directly to their investment team.
As of October 2023: Pappas Capital has been active in the market, with recent highlights including Aktis Oncology's initial public offering and Cadrenal Therapeutics' acquisition of a new therapeutic asset.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.